SeerPharma congratulates the latest cohort of Postgraduate GMP Graduates from UTS.
Recent Posts
Unlock the future of training at our upcoming webinar, showcasing innovative student projects from The University of Melbourne's Master of Biotechnology program. In collaboration with SeerPharma, the students have explored the application of emerging technologies like Augmented Reality (AR), immersive 360-degree video, and chatbot assessments to...
30th October 2024 | 2:00p.m – 3:00 p.m. AEDT
The Parenteral Drug Association (PDA) is the foremost global provider of scientific, technological, and regulatory education and resources for the pharmaceutical and biopharmaceutical sectors. Established in 1946 as a nonprofit organisation, PDA is dedicated to advancing science and regulation through the expertise of its nearly 10,000 members...
Why FDA Product Recalls Happen and How to Avoid Them
When the U.S. Food and Drug Administration (FDA) initiates the recall of a product, it’s costly for life sciences companies, causing significant financial losses, reputation damage, and even legal repercussions. In the past several years, FDA recalls have been on the rise, especially in the...
A multinational manufacturer of cardiovascular devices recently engaged SeerPharma to conduct a comprehensive mock US FDA audit of their operations in Singapore. The audit was conducted against US FDA 21 CFR Part 820 – Quality System Regulation (21 CFR 820). SeerPharma reviewed relevant documentation remotely and then spent three days on-site...
Artificial Intelligence (AI) and emerging technologies are rapidly advancing, influencing every aspect of business operations, including the biotechnology and life sciences sectors.
A decade ago, Duke-NUS Medical School established the Centre of Regulatory Excellence (CoRE) to enhance health products regulatory systems and competency across ASEAN and the broader Asia-Pacific region. CoRE is pivotal in supporting policy innovation and facilitating progress towards effective and efficient health products regulation. As a...
VIMTA is a leading contract research and testing organisation headquartered in India, serving the pharmaceutical, food, and general manufacturing sectors. With over 40 years of experience and a global presence, VIMTA is at the forefront of supporting pharmaceutical companies with their outsourced product development and discovery activities.
SeerPharma consults on 100 to 150 projects every year. Many of these engagements with pharmaceutical and medical device companies involve providing ongoing support for business needs related to Quality Assurance (QA) and Good Manufacturing Practice (GMP) compliance. Our clients continue to rely on our expertise for regular remote and on-site...
